CONFERENCE ON SELF-DESTRUCTING (SINGLE-USE) SYRINGES

开发和普遍采用自毁或一次性使用， 针头和注射器可能会防止随意重复使用和分享这些 设备。用于预防血液传播的注射器的研制 人类免疫缺陷病毒(HIV)和其他病原体的传播 至少从1984年就开始提倡了。许多这样的设备已经被 看起来实用、有效和经济的专利。 尽管如此，自毁注射器的生产和广泛使用 没有发生。 “关于自毁(一次性)皮下注射器的会议”是 提出的目标是评估概念和当前的设计， 刺激进一步发展，并探索阻碍 实施。需要审查的具体问题包括(1) 自毁注射器设计的艺术；(2)潜在的有效性 防止针头共用的自毁注射器 注射药物滥用者；(3)其潜在的减少 保健过程中传染病的不经意传播 提供和接种疫苗方案；(4) 自毁针的发展和自毁针的发展 自动保护卫生工作者免受意外刺伤；以及(5) 可能会反对这种做法的社会法律和务实问题 解决两国重复使用注射器带来的问题的技术解决方案 合法和非法用户。 大会将在纽约市纽约大学医学院校园内举行 中心为期1.5天，1991年4月18日至19日左右。共有150名注册人 预计听众将由学术界人士组成 社区，包括那些从事药物滥用研究的人，医学 工程学和流行病学；企业界，包括注射器 制造商和个人发明者；世界卫生组织；以及 联邦、州和地方政府，包括来自 国家药物滥用研究所、食品和药物管理局、 美国国家职业健康与安全研究所 疾病控制部门、卫生部和地区检察官办公室。

The development and universal adoption of self-destructing, or single-use, needles and syringes could prevent the casual re-use and sharing of these devices. Development of such syringes for prevention of blood-borne transmission of human immunodeficiency virus (HIV) and other pathogens has been advocated since at least 1984. A number of such devices have been patented that appear to be practical, effective and economical. Nonetheless, production and widespread use of self-destructing syringes has not occurred. A "Conference on Self-destructing (Single-use) Hypodermic Syringes" is proposed with the goals of evaluating the concept and current designs, stimulating further development, and exploring impediments to implementation. Specific issues to be examined include (1) the state of the art of self-destructing syringe design; (2) potential effectiveness of self-destructing syringes for the prevention of needle-sharing among injected substance abusers; (3) their potential utility for reducing inadvertent spread of infectious organisms in the course of health care delivery and vaccination programs; (4) relationships between the development of self-destructing needles and the development of needles that automatically protect health workers from accidental needle sticks; and (5) socio-legal and pragmatic issues that might argue against such a "technological fix" to the problems posed by reused syringes among both licit and illicit users. The conference will be held in New York City on the campus of NYU Medical Center for 1.5 days around April 18-19, 1991. A total of 150 registrants is expected with the audience comprised of persons from the academic community, including those engaged in the study of substance abuse, medical engineering and epidemiology; the business community, including syringe manufacturers and individual inventors; the World Health Organization; and the federal, state and local governments, including persons from the National Institute on Drug Abuse, the Food and Drug Administration, the National Institute on Occupational Health and Safety, the Centers for Disease Control, departments of health and district attorneys offices.